Co-Diagnostics Reaches $6.5 Million Settlement in Class Action Suit
A $6.5 million settlement has been reached in a class action lawsuit involving Co-Diagnostics, Inc., potentially resolving claims brought by investors who purchased the company’s common stock or options between May 12, 2022, and August 11, 2022, following allegations of financial damages during that period.





















